Artificial Intelligence

Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced its external digital slide quality assessments to support laboratories in achieving good-quality histology slides—essential for...

Join Aiforia for their latest webinar! Developing an AI tool for renal pathology: case Galileo Monday, December 16 10:00-11:00 a.m. EST / 4:00-5:00 p.m. CET Register Now Summary Join this webinar to discover how artificial...

Philips: Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global...

Mount Sinai: New state-of-the-art facility is among the first of its kind at a U.S. medical school New York, NY, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Today, the Mount Sinai Health System, one of New York City’s largest academic medical systems,...

PreciseDX: World-Renowned Breast Cancer Oncology and Pathology Experts to Advise Company on the Advancement of its AI-Powered PreciseBreastTM Risk of Recurrence Assessment and Product Portfolio NEW YORK, Nov. 20, 2024 /PRNewswire/...

Deep Bio: Integrating Deep Bio's DeepDx Prostate Algorithm into PathAI's AISight IMS Platform SEOUL, SOUTH KOREA, November 19, 2024 /EINPresswire.com/ -- Deep Bio, a leader in artificial intelligence for digital pathology, announced a...